Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 9:39 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 3121–3144 of 4,278 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Computer Application Clear all

Conditions: Atopic Dermatitis
Interventions: Clobetasol propionate 0.05% Topical Oil; Drug
Lead sponsor: Hill Dermaceuticals, Inc.; Industry
Eligibility: 2 Years to 18 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 6
States / cities: Sanford, Florida • Savannah, Georgia • Philadelphia, Pennsylvania + 3 more

Conditions: Schizophrenia and Related Disorders
Interventions: Cognitive Enhancement Therapy, Social Skills Training; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 378 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 5
States / cities: Hartford, Connecticut • Portland, Maine • Boston, Massachusetts + 1 more

Conditions: Diabetes Mellitus, Type 2
Interventions: BT-001, Control App; Behavioral · Other
Lead sponsor: Better Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 3
States / cities: Aurora, Colorado • New Orleans, Louisiana • Durham, North Carolina

Conditions: Sarcopenia, Frailty
Interventions: BandPass System; Device
Lead sponsor: SynchroHealth LLC; Industry
Eligibility: 65 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 2
States / cities: Chapel Hill, North Carolina

Conditions: Seborrheic Keratosis
Interventions: SM-020 gel 1.0%, Vehicle gel; Drug
Lead sponsor: DermBiont, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 4
States / cities: Coral Gables, Florida • New Brighton, Minnesota • Portland, Oregon

Conditions: Wound Bleeding
Interventions: BXP154, Placebo; Drug
Lead sponsor: Bio 54, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: DeLand, Florida

Conditions: Poverty, Social Determinants of Health, Mobile Applications, Pediatric ALL, Emergencies
Interventions: HelpSteps application; Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 266 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cervical Cancer, Uterine Cancer, Vaginal Cancer, Carcinoma of the Vulva
Interventions: Image-guided brachytherapy, 3'-Deoxy-3'-18f-Fluorothymidine; Procedure · Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Emergencies
Interventions: Babies in the Owlet monitor group; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 22 Weeks to 6 Months
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Knee Osteoarthritis, Central Pain Syndrome
Interventions: Transcutaneous vagus nerve stimulation; Device
Lead sponsor: University of Texas, El Paso; Other
Eligibility: 45 Years to 90 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Dermatitis, Atopic
Interventions: Triamcinolone 0.1%; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 75 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Sunscreening Agents
Interventions: BAY987521, SPF Control; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Union, New Jersey

Conditions: GLAUCOMA 1, OPEN ANGLE, D (Disorder)
Interventions: DSLT treatment for Open-Angle Glaucoma, SLT treatment for Open-Angle Glaucoma; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Deep Partial or Full Thickness Wounds
Interventions: Fibrin Sealant, ARTISS 4IU/ml VH SD, Staples; Biological · Other
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: Up to 65 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 17
States / cities: Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 14 more

Conditions: Osteoarthritis
Interventions: Omnibond Topical Skin Adhesive, Dermabond Advanced Topical Skin Adhesive; Device
Lead sponsor: Center for Innovation and Research Organization; Network
Eligibility: 18 Years and older
Enrollment: 310 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 4
States / cities: New York, New York • New Albany, Ohio • Philadelphia, Pennsylvania + 1 more

Conditions: Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma
Interventions: AU-011, Suprachoroidal Microinjector, PDT Laser; Drug · Device
Lead sponsor: Aura Biosciences; Industry
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 22
States / cities: Tucson, Arizona • Los Angeles, California • Palo Alto, California + 19 more

Conditions: Photoallergy
Interventions: Induction: Application of MC2-01 Cream, irradiation, Induction: Application of MC2-01 Cream, no irradiation, Induction: Applications of MC2-01 vehicle, irradiation, Induction: Applications of MC2-01 vehicle, no irradiation, Challenge: Application of MC2-01 Cream, irradiation, Challenge: Application of MC2-01 Cream, no irradiation, Challenge: Applications of MC2-01 vehicle, irradiation, Challenge: Applications of MC2-01 vehicle, no irradiation, Challenge: Control, irradiation; Drug
Lead sponsor: MC2 Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Fair Lawn, New Jersey

Conditions: Sunscreening Agents
Interventions: CAP UnScented, CAP Herbal Mint, CAP Mountain Berry, SPF Standard Sunscreen; Drug
Lead sponsor: HALEON; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Bladder Cancer
Interventions: LifeScience Technologies application; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Diabetes, Pre Diabetes
Interventions: Viome's Precision Nutrition Program (VPNP); Dietary Supplement
Lead sponsor: Viome; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Bothell, Washington

Conditions: Fibromyalgia, Multiple Sclerosis, Osteoarthritis, Sjögren's Syndrome, Parkinson's Disease
Interventions: Computer Tablet Group, Paper and Pencil Group, Contact Control Group; Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 18 Years to 76 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Gastroparesis
Interventions: Granisetron; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Anxiety and Fear
Interventions: The intervention was the AI-based emotional support app., Psychoeducational Material; Device · Other
Lead sponsor: University of Cologne; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Agitated; State, Acute Reaction to Stress, Agitation,Psychomotor
Interventions: Music; Other
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 18 Years and older
Enrollment: 172 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Syracuse, New York

Search by objective public record fields.

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis

Comparative Effectiveness of CET vs. SST in SMI (Serious Mental Illness)

Digital Therapeutic Based Investigation to Improve Glycemic Control in Patients With Type 2 Diabetes and Residual Hyperglycemia on Stable Medical Therapy

BandPass: A Remote Monitoring System for Sarcopenia and Functional Decline Phase II Aim 4

A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis

Treatment of Post-Punch Biopsy Bleeding in Anticoagulated Patients Using Self-Administered BXP154

Mobile-based Social Services Screening and Referral Tool in an Pediatric Emergency Department

Image-Guided Gynecologic Brachytherapy

Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization

Effects of Vagus Nerve Stimulation on Central Pain Sensitivity & Parasympathetic Function in Knee Osteoarthritis

A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal

Sun Protection Factor Assay (317/2016)

Direct vs. Conventional SLT in Open-Angle Glaucoma: A RCT

Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients

Omnibond vs Dermabond

Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Evaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream

Clinical Study to Evaluate the 80-Minute Water Resistant Sun Protection Factor (SPF) of Sunscreen Products

Application-based Perioperative Management of the Radical Cystectomy Patient

Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c

e-Mobile Tablet for People With Chronic Conditions

Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis

Trial of a Voice-Based Generative AI Emotional Support Companion

Mindful Melody: Feasibility of Implementing Music Listening on an Inpatient Psychiatric Unit and Its Relation to the Use of As Needed Medications for Acute Agitation